Derek J. Erstad
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
Papers in
- Hepatology 12
- Hepatocellular Carcinoma Treatment and Prognosis 8
- Liver physiology and pathology 3
-
- Cancer, Lipids, and Metabolism 5
- Cancer, Hypoxia, and Metabolism 4
- Co-authors
- Kenneth K. TanabeJames C. CusackBryan C. FuchsPeter CaravanMozhdeh SojoodiEric M. GaleIan RamsayMichael Lanuti
- Journals
- Annals of Surgical Oncology (10 papers)Journal of Hepatology (4 papers)Journal of the American College of Surgeons (3 papers)Scientific Reports (2 papers)Cancers (2 papers)
- Partner nations
- United StatesChinaFrance
In The Last Decade
Derek J. Erstad
46 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Hepatology 355
- Cancer Research 270
- Oncology 347
- Radiology, Nuclear Medicine and Imaging 215
- Epidemiology 208
Countries citing papers authored by Derek J. Erstad
This map shows the geographic impact of Derek J. Erstad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek J. Erstad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek J. Erstad more than expected).
Fields of papers citing papers by Derek J. Erstad
This network shows the impact of papers produced by Derek J. Erstad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek J. Erstad. The network helps show where Derek J. Erstad may publish in the future.
Co-authors
The 25 scholars most cited alongside Derek J. Erstad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 14 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 29 | |
| 7 | Neoadjuvant Therapy for Melanoma – New and Evolving Concepts | 2022 | 4 |
| 8 | 2022 | 6 | |
| 9 | 2022 | 6 | |
| 10 | 2022 | 1 | |
| 11 | 2022 | 14 | |
| 12 | 2021 | 2 | |
| 13 | 2021 | 4 | |
| 14 | 2021 | 6 | |
| 15 | 2021 | 0 | |
| 16 | 2020 | 20 | |
| 17 | 2019 | 44 | |
| 18 | Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma Hit paper breakdown → | 2019 | 301 |
| 19 | 2018 | 36 | |
| 20 | 2017 | 2 |
About Derek J. Erstad
Derek J. Erstad is a scholar working on Hepatology, Cancer Research, Oncology, Epidemiology and Cell Biology, having authored 50 papers that have together received 1.2k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Sarcoma Diagnosis and Treatment (6 papers), Cancer, Lipids, and Metabolism (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), Endoplasmic Reticulum Stress and Disease (4 papers), MRI in cancer diagnosis (3 papers) and Liver physiology and pathology (3 papers). The work is most often cited by research in Hepatology (355 citations), Cancer Research (270 citations), Oncology (347 citations), Radiology, Nuclear Medicine and Imaging (215 citations) and Epidemiology (208 citations). Derek J. Erstad has collaborated with scholars based in United States, China and France. Frequent co-authors include Kenneth K. Tanabe, James C. Cusack, Bryan C. Fuchs, Peter Caravan, Mozhdeh Sojoodi, Eric M. Gale, Ian Ramsay, Michael Lanuti, Yujin Hoshida and Sarani Ghoshal. Their work appears in journals such as Annals of Surgical Oncology, Journal of Hepatology, Journal of the American College of Surgeons, Scientific Reports and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.